Abstract
Lysophosphatidic acid (LPA), an initiator of neuropathic pain, causes allodynia. However, few studies have evaluated the pharmacological profile of LPA-induced pain. In this study, a LPA-induced pain model was developed and pharmacologically characterized with clinically relevant drugs used for neuropathic pain, including antiepileptics, non-steroidal anti-inflammatory agents, analgesics, local anaesthetics/antiarrhythmics and antidepressants. Gabapentin (1-30 mg/kg, p.o.) significantly reversed LPA-induced allodynia, but neither indomethacin (30 mg/kg, p.o.) nor morphine (0.3-3 mg/kg, s.c.) did, which indicates that LPA-induced pain consists mostly of neuropathic rather than inflammatory pain. Both pregabalin (0.3-10 mg/kg, p.o.) and ω-CgTX MVIIA (0.01-0.03 μg/mouse, i.t.) completely reversed LPA-induced allodynia in a dose-dependent manner. Lidocaine (1-30 mg/kg, s.c.), mexiletine (1-30 mg/kg, p.o.) and carbamazepine (10-100 mg/kg, p.o.) significantly ameliorated LPA-induced allodynia dose dependently. Milnacipran (30 mg/kg, i.p.) produced no significant analgesic effect in LPA-induced allodynia. In LPA-injected mice, expression of the α2δ1 subunit of the voltage-gated calcium channel (VGCC) was increased in the dorsal root g...Continue Reading
References
May 1, 1994·Neurology·N I ChernyR K Portenoy
Jan 1, 1997·Pain·M F JettJ C Hunter
Aug 26, 1998·Neurology·C SolaroG L Mancardi
Dec 8, 1998·Anesthesia and Analgesia·S AbdiJ M Chung
Feb 10, 2000·Pain·Y X WangS Scott Bowersox
Mar 18, 2000·Brain Research·W C CoveyR N Spengler
Jul 20, 2001·British Journal of Anaesthesia·D BridgesA S Rice
Apr 5, 2002·Pain·Maree T SmithRichard J Lewis
Nov 29, 2002·Anesthesia and Analgesia·Chandra K PandeyUttam Singh
May 6, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yukinori NagakuraTokio Yamaguchi
Sep 23, 2003·Pain·Alyson FoxStuart Bevan
Jan 14, 2004·The Journal of Pharmacology and Experimental Therapeutics·Md Harunor RashidHiroshi Ueda
Jun 15, 2004·Nature Medicine·Makoto InoueHiroshi Ueda
Jun 25, 2004·Journal of Pharmacological Sciences·Akiko SakaueHideki Ono
Jan 24, 2006·The Journal of Pain : Official Journal of the American Pain Society·John D Markman, Robert H Dworkin
Jun 13, 2006·Pain·Chun-Ying LiZ David Luo
Sep 25, 2007·Neuropharmacology·Yuichi TakeuchiMitsuo Tanabe
Mar 20, 2008·Anesthesia and Analgesia·Takahiro SuzukiTakashi Mashimo
Apr 2, 2008·Molecular Pain·Hiroshi Ueda
Apr 11, 2008·Neuroscience·T KisoN Matsuoka
Jan 9, 2009·Pain·Charles P Taylor
Feb 19, 2009·Journal of Neurochemistry·Lin MaHiroshi Ueda
Apr 17, 2009·Brain Research·Wei-Shi ZhangYu-Qiu Zhang
Sep 5, 2009·Journal of Pharmacological Sciences·Kazuhisa MinamiAkira Kato
Mar 17, 2010·Brain Research·Feng-Yu LiuGuo-Gang Xing
Jan 8, 2011·Pain·Soichiro OhnamiHideki Ono
Citations
Nov 30, 2013·Progress in Lipid Research·Marco SisignanoKlaus Scholich
Sep 30, 2014·Peptides·Richard J Bodnar
Jan 8, 2016·Journal of Pharmacological and Toxicological Methods·Kenshiro MatsudaAkane Tanaka
Nov 21, 2014·Molecular Pain·Hitoshi UchidaHiroshi Ueda
Jun 6, 2015·Neuropharmacology·Matthieu RoussetPierre Charnet
Apr 10, 2016·Neuropharmacology·María VelascoGraham K Sheridan
Jan 2, 2014·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Amarjot Kaur GrewalNirmal Singh
May 30, 2013·British Journal of Pharmacology·A JayamanneC W Vaughan
Mar 20, 2021·European Journal of Pharmacology·Shiori KawasakiMasahide Fujita
Apr 17, 2021·Journal of Pharmacological Sciences·Misa OyamaMitsuo Tanabe